Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: wvalx who wrote (20347)	4/8/1999 6:44:00 PM
From: VLAD	Respond to of 23519

wvalx, We know that good news is coming: 1)profitable Q1 2)Spain approval for $2M 3)Italy approval for $2M 4)Deal for Japan 5)AstraZeneca launches MUSE in full force next month. 6)Good proVivus presentations in Mays AAU meeting 7)Big future income potential on female SD product (can happen quick if Vivus can get its act together). Purely from a technical perspective showing good support at 3.5 with 6M+ shares that still need covering. Trading range narrowing and volume decreasing which usually is a preclude to a nice move to the upside. As far as the rest of the market goes....same sh#t different day. Sheep like fund managers keep throwing $$$ at the same 50 big cap stocks. Sooner or later the money will have to pour into the small cap index but who knows when?